European Innovation Council

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

ResoTher Pharma is a privately held biotechnology company based in Copenhagen, Denmark. The company specializes in developing peptide-based drugs derived from Annexin A1, an endogenous immunomodulator. These drugs are designed as resolution therapies for diseases where neutrophil-driven inflammation is a key pathological factor. ResoTher Pharma's primary focus is on addressing cardiovascular and inflammatory disorders that have significant unmet medical needs. Their patented peptide drugs target a G-protein coupled receptor expressed on leukocytes, aiming to mimic the body's natural response to resolving inflammation and promoting tissue repair.

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Founded in 2022, Kvantify is headquartered in Copenhagen, Denmark. It specializes in quantum computing management software, offering solutions to address computational challenges across various industries such as life sciences, financial services, and logistics.

Abzu is a company that develops a scientific artificial intelligence platform aimed at accelerating drug discovery and bringing pharmaceuticals to market more efficiently. Founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain, Abzu challenges traditional, opaque AI methods by utilizing its pioneering technology, the QLattice. This platform provides transparent and explainable models that enable data scientists to approach their work with a scientific mindset. By unlocking new disease mechanisms, discovering novel biomarkers, and designing improved drugs, Abzu empowers pharmaceutical and biotech companies to validate multiple targets simultaneously, thereby enhancing their research capabilities and reducing development costs.

Founded in 2014, Seaborg Technologies develops and operates thorium-based molten salt reactors (MSRs) for clean energy production. The company also designs software tools to assist MSR companies and aims to provide affordable, sustainable nuclear power.

Founded in 2016, Kaffe Bueno specializes in transforming coffee waste into valuable ingredients using proprietary biotechnology. The company produces coffee oils, coffee flour, and coffee beans for use in cosmetics, functional foods, and nutraceuticals, aiming to minimize harmful emissions and maximize the usability of coffee's by-products.

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

Electrochaea develops and commercializes power-to-gas technology that converts renewable electricity into pipeline-grade natural gas. This enables large-scale energy storage, grid balancing, and carbon recycling.

Electrochaea develops and commercializes power-to-gas technology that converts renewable electricity into pipeline-grade natural gas. This enables large-scale energy storage, grid balancing, and carbon recycling.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.